Selank
Anxiolytic Nootropic Peptide

Dosage
10mg
Unit Size
1 Vial
// Add to Cart
10mg
$80.00
24 in stock
What is Selank?
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide Tuftsin, developed by the Institute of Molecular Genetics in Russia. It is one of the most studied nootropic peptides for its dual role as both a cognitive enhancer and anxiolytic — improving mental clarity and focus while simultaneously reducing anxiety and stress without sedation or dependence risk.
7 aa
Amino Acid Chain
GABA-A
Key Receptor Interaction
Non-Sedating
Anxiolytic Profile
Key Benefits
Anxiety Reduction
Reduces anxiety and stress responses without sedation — a unique anxiolytic profile studied in clinical settings in Russia.
Cognitive Enhancement
Supports working memory, attention, and information processing in research models and human trials.
Focus & Concentration
Enhances sustained attention and focus, making it a studied compound for cognitive performance optimization.
Mood Stability
Promotes emotional resilience and mood stability through modulation of serotonin and dopamine pathways.
Neuroprotection
Exhibits neuroprotective effects by supporting BDNF levels and reducing neuroinflammatory markers.
Immune Modulation
Derived from Tuftsin, Selank retains immunomodulatory properties — studied for balancing immune function under chronic stress.
How It Works
GABA-A Receptor Modulation
Selank modulates GABA-A receptor activity, producing calming effects without the sedation or dependency risk associated with benzodiazepines.
Enkephalin System Interaction
Like Semax, Selank inhibits enzymes that degrade enkephalins, elevating endogenous peptides that regulate stress and emotional balance.
Serotonin & Dopamine Pathway Support
Enhances serotonergic and dopaminergic neurotransmission, supporting mood stability, motivation, and reward processing.
BDNF Upregulation
Stimulates BDNF production, supporting neuronal health, synaptic plasticity, and the long-term cognitive benefits seen in preclinical research.
Common Protocol (Research Reference)
250–500 mcg
Dose per session
1–2×/day
Frequency (intranasal)
2–4 wks
Typical cycle length
Research Use Notice
Selank is a research peptide not approved by the FDA for human use. This information is for educational purposes only. Always consult a qualified healthcare professional before considering any peptide protocol.
